Cost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: results from the Nutrition Education for Management of Osteodystrophy trial

References

• Roman-Garcia P, Carrillo-Lopez N, Cannata-Andia JB. Pathogenesis of bone and mineral related disorders in chronic kidney disease: Key role of hyperphosphatemia. J Ren Care 2009;35(Suppl):34-8
   PubMedGoogle Scholar
• Fernandez-Martin JL, Martinez-Camblor P, Dionisi MP, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: The COSMOS study. Nephrol Dial Transplant 2015;30:1542-51
   PubMed Web of Science ®Google Scholar
• Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011;26:1948-55
   PubMed Web of Science ®Google Scholar
• Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008;52:519-30
   PubMed Web of Science ®Google Scholar
• Naves-Diaz M, Passlick-Deetjen J, Guinsburg A, et al. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant 2011;26:1938-47
   PubMed Web of Science ®Google Scholar
• White DA, Odedina F, Xiao H, et al. The economic burden of end-stage renal disease with hyperphosphatemia. Dis Manag Health Outcomes 2012;14:99-106
   Web of Science ®Google Scholar
• Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:1-201
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009;76(Suppl):1-130
   Google Scholar
• Port FK. Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 2006;1:246-55
   PubMed Web of Science ®Google Scholar
• Fernandez-Martin JL, Carrero JJ, Benedik M, et al. COSMOS: The dialysis scenario of CKD-MBD in Europe. Nephrol Dial Transplant 2013;28:1922-35
   PubMed Web of Science ®Google Scholar
• Rizk R, Hiligsmann M, Karavetian M, et al. Economic evaluations of interventions to manage hyperphosphataemia in adult haemodialysis patients: A systematic review. Nephrology 2016;21:178-87
   PubMed Web of Science ®Google Scholar
• Karavetian M, de Vries N, Rizk R, et al. Dietary educational interventions for management of hyperphosphatemia in hemodialysis patients: A systematic review and meta-analysis. Nutr Rev 2014;72:471-82
   PubMed Web of Science ®Google Scholar
• Karavetian M, Abboud S, Elzein H, et al. Nutritional education for management of osteodystrophy (NEMO) trial: Design and patient characteristics, Lebanon. Nutr Res Pract 2014;8:103-11
   PubMed Web of Science ®Google Scholar
• Karavetian M, de Vries N, Elzein H, et al. Effect of behavioral stage-based nutrition education on management of osteodystrophy among hemodialysis patients, Lebanon. Patient Educ Couns 2015;98:1116-22
   PubMed Web of Science ®Google Scholar
• Karavetian M, Elzein H, Rizk R, et al. Nutritional education for management of osteodystrophy: Impact on serum phosphorus, quality of life, and malnutrition: NEMO: impact on QOL and malnutrition. Hemodial Int 2016;20:432-40
   PubMed Web of Science ®Google Scholar
• Rizk R, Karavetian M, Hiligsmann M, et al. Effect of stage-based education provided by dedicated dietitians on hyperphosphataemic haemodialysis patients: results from the Nutrition Education for Management of Osteodystrophy (NEMO) randomised controlled trial. J Hum Nutr Diet 2017. DOI: 10.1111/jhn.12472
   PubMedGoogle Scholar
• Drummond M, Sculpher M, Torrance G, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005
   Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Cost Eff Resour Alloc 2013;11:6
   PubMedGoogle Scholar
• Weinstein MC. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-8
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kopple JD, Block G, et al. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 2001;12:2797-806
   PubMed Web of Science ®Google Scholar
• Sabbah I, Drouby N, Sabbah S, et al. Quality of life in rural and urban populations in Lebanon using SF-36 health survey. Health Qual Life Outcomes 2003;1:30
   PubMedGoogle Scholar
• Rizk R, Hiligsmann M, Karavetian M, et al. A societal cost-of-illness study of hemodialysis in Lebanon. J Med Econ 2016;19:1157-66
   PubMed Web of Science ®Google Scholar
• Data Series [Internet]. 2011. Beirut: Banque du Liban. http://www.bdl.gov.lb/statistics/table.php?name¼t5282usd. Accessed October 3, 2016
   Google Scholar
• Consumer Prices [Internet]. 2016. Paris: Organisation for Economic Cooperation and Development (OECD). http://stats.oecd.org/index.aspx?DatasetCode=MEI_PRICES. Accessed October 3, 2016
   Google Scholar
• Ministry of Public Health of Lebanon. Lebanon National Drug Index. 4th ed. Beirut: Ministry of Public Health of Lebanon; 2011
   Google Scholar
• Koopmanschap MA, van Exel NJA, van den Berg B, et al. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics 2008;26:269-80
   PubMed Web of Science ®Google Scholar
• Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 1990;6:57-75
   PubMedGoogle Scholar
• van Mastrigt G, van Asselt T, Kessels F, et al. How to deal with imbalances in baseline utility between treatment groups in quality adjusted life year calculations. G. van Mastrigt [dissertation], Outcome assessment and economic evaluation of short-stay intensive care for coronary artery bypass patients. Maastricht: Maastricht University; 2009:119-35
   Google Scholar
• Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92
   PubMed Web of Science ®Google Scholar
• Grima DT, Bernard MLM, Dunn ES, et al. Cost-effectiveness analysis of therapies for chronic kidney disease patients on dialysis. Pharmacoeconomics 2012;30:981-9
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Curtin RB, LePain N, et al. Medical outcomes study short form-36: A consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 2003;41:1286-92
   PubMed Web of Science ®Google Scholar
• Marseille E, Larson B, Kazi DS, et al. Thresholds for the cost–effectiveness of interventions: Alternative approaches. Bull World Health Organ 2015;93:118-24
   PubMed Web of Science ®Google Scholar
• International Monetary Fund, World Economic Outlook Database. 2012. Gross domestic product per capita, current prices (U.S. dollars) [Internet]. Washington: International Monetary Fund – World Economic Outlook. http://www.imf.org/external/pubs/ft/weo/2014/01/weodata/weorept.aspx?pr.x=77&pr.y=10&sy=2012&ey=2019&scsm=1&ssd=1&sort=country&ds=.&br=1&c=446&s=NGDPDPC&grp=0&a=. Accessed October 14, 2016
   Google Scholar
• NICE. The guidelines manual [Internet]. 2012. London: The National Institute for Health and Care Excellence (NICE). https://www.nice.org.uk/process/pmg6/chapter/assessing-cost-effectiveness. Accessed October 14, 2016
   Google Scholar
• Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold. N Engl J Med 2014;371:796-7
   PubMed Web of Science ®Google Scholar
• Pisetkul C, Chanchairujira K, Chotipanvittayakul N, et al. Malnutrition-inflammation score associated with atherosclerosis, inflammation and short-term outcome in hemodialysis patients. J Med Assoc Thai 2010;93(Suppl):147-56
   PubMedGoogle Scholar
• Kalantar-Zadeh K, Kopple JD, Block G, et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001;38:1251-63
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kopple JD, Humphreys MH, et al. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004;19:1507-19
   PubMed Web of Science ®Google Scholar
• Rambod M, Bross R, Zitterkoph J, et al. Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: A 5-year prospective cohort study. Am J Kidney Dis 2009;53:298-309
   PubMed Web of Science ®Google Scholar
• Qunibi WY. Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD). Kidney Int 2004;66(Suppl):8-12
   Web of Science ®Google Scholar
• Brennan A, Akehurst R, Davis S, et al. The cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in patients with end-stage renal disease. Value Health 2007;10:32-41
   PubMed Web of Science ®Google Scholar
• van Asselt ADI, van Mastrigt GAPG, Dirksen CD, et al. How to deal with cost differences at baseline. PharmacoEconomics 2009;27:519-28
   PubMed Web of Science ®Google Scholar
• Thorn JC, Coast J, Cohen D, et al. Resource-use measurement based on patient recall: Issues and challenges for economic evaluation. Appl Health Econ Health Policy 2013;11:155-61
   PubMedGoogle Scholar
• Evers S, Goossens M, De Vet H, et al. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Health Care 2005;21:240-5
   PubMed Web of Science ®Google Scholar
• Annual Report – 2012 [Internet]. 2012. Beirut: Lebanese Kidney Registry. http://kidneyregistrylb.com/national-registry-2/annual-report-2012/. Accessed October 16, 2016
   Google Scholar
• Lacson E, Ikizler TA, Lazarus JM, et al. Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs. J Ren Nutr 2007;17:363-71
   PubMed Web of Science ®Google Scholar
• Ebrahimi H, Sadeghi M, Amanpour F, et al. Influence of nutritional education on hemodialysis patients’ knowledge and quality of life. Saudi J Kidney Dis Transplant 2016;27:250-5
   PubMed Web of Science ®Google Scholar
• Wiser NA, Shane JM, McGuigan AT, et al. The effects of a group nutrition education program on nutrition knowledge, nutrition status, and quality of life in hemodialysis patients. J Ren Nutr 1997;7:187-93
   Google Scholar
• Karavetian M, Rizk R. Development and evaluation of continuing education course in renal nutrition. Nutr Res Pract 2016;10:99-107
   PubMed Web of Science ®Google Scholar
• Karavetian M, Elzein H, Hwalla N, de Vries N. Dietetic practices in hemodialysis units in Lebanon and their conformity with KDOQI nutrition guidelines. Int J Health Nutr 2013;4:1-8
   Google Scholar